Global focus event: Connecting insights from the evidence-support ecosystem to make progress towards WHO’s Triple Billion Targets

Tuesday, 16 November 2021, 15:00-17:30 CET

Interpretation available: ARA, FRA, POR, RUS, SPA

> Session flyer

Background: The COVID-19 pandemic has been a game changer in how those supporting evidence-informed decision-making (EIDM) think about using evidence to strengthen health systems. New formats for rapidly prepared evidence products (e.g. regularly updated ‘living’ rapid syntheses and living rapid evidence profiles) were developed around the world to meet a significant increase in demand for such products by decision-makers who needed to stay on top of a rapidly evolving evidence base. Furthermore, many processes were drawn upon to engage the full range of stakeholders in the evidence-support ecosystem, with the aim of leveraging all of the forms in which evidence is typically encountered in decision-making (i.e., data analytics, modelling, evaluation, behavioural/ implementation research, evidence supports, technology assessment/cost-effectiveness analysis, guidelines). 

Ensuring efforts to support EIDM are inclusive of all relevant stakeholders producing decision-relevant evidence (and their evidence outputs) as part of the evidence-support ecosystem is increasingly viewed as one of the most important aspects of supporting decision-makers with access to the best-available, context-relevant, research evidence in formats that they can use. As EVIPNet teams continue to support EIDM in ways that will contribute to the achievement of WHO’s Triple Billion Targets, linking up stakeholders from the evidence-support ecosystem in order to leverage insights from all forms in which evidence is typically encountered is key.

Objective: This global focus event aims to gather insights as a way to inform the development of a practical set of tools for use among those supporting EIDM. In particular, it will build on insights from previous meetings convened by EVIPNet in London and Beirut, a new WHO EIDM Guidance as well as lessons learned from COVID-END and the Global Commission on Evidence to Address Societal Challenges to help individuals and teams supporting EIDM to work with outputs from the entire evidence-support ecosystem. 

Session participants: This virtual session will invite 20-40 panelists who are involved in efforts to support EIDM from across all WHO regions (as well as individuals working at the international level), to actively participate in deliberations in each session. It will also allow individuals to join as observers and engage in the discussion by posting questions to the panelists while interacting with other participants through live chat. 

Session structure and agenda: The session will be virtual and last 2.5 hours. It will be structured into five sections, with the first providing participants with background information, and sessions 2-5 structured around an illustrative example and set of key questions (see agenda below). Each session will be framed by a panelist who can briefly introduce the topic with an illustrative example, and orient participants to key questions.

Agenda

Title
Focus of the Session
Time (CET)
Welcome, introductions and background
To provide participants with an overview of the session. To discuss lessons learned from COVID-19 about innovative products and processes, the forms of evidence typically encountered by decision-makers, and things other than ‘best evidence’ that received greater attention during the pandemic
3:00-3:15pm
Processes deliberation
To provide an illustrative example of the types of processes that can be used to enable the development of innovative products To answer the question: What kinds of processes do EVIPNet teams need to engage in to enable the development of innovative products that integrate all forms of evidence available in the evidence-support ecosystem (e.g., stakeholder mapping)?
3:45-4:15pm
Products deliberation
To provide an illustrative example of an innovative approach to developing evidence products To answer the question: What types of innovative products should be supported by EVIPNet teams and other country-level knowledge intermediary organizations to integrate all forms of evidence available in the evidence-support ecosystem (e.g., evidence briefs, rapid-evidence profiles)?
3:15 – 3:45pm
Supports for products and processes deliberation
To provide an illustrative example of supplementary supports that can be used to support innovative processes and products To answer the question: What kinds of supplementary supports are required to help EVIPNet teams and other knowledge intermediary organizations better understand the evidence-support ecosystem, and how innovative products and processes can help bring together the full range of insights from the forms of evidence typically encountered by decision-makers (e.g., decision trees, flow diagrams, ‘nano’ courses and videos)?
4:15 – 5:00pm
Next steps deliberation
To answer the question: What next steps should be taken at the international, regional and country level to develop supports for products and processes (e.g., digitizing a flow diagram or decision tree to help users)?
5:00 – 5:30pm

Facilitator

Speakers